This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Generic Name
- Bismuth oxide
- DrugBank Accession Number
- DB15929
- Background
Not Available
- Type
- Small Molecule
- Groups
- Experimental
- Structure
Structure for Bismuth oxide (DB15929)
- Weight
- Average: 465.958
Monoisotopic: 465.94554 - Chemical Formula
- Bi2O3
- Synonyms
- Bismuth trioxide
- Bismuth yellow
- Bismuthous oxide
- Bismuthum oxydatum
- Dibismuth trioxide
- External IDs
- 215-134-7
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Associated Conditions
Indication Type Indication Combined Product Details Approval Level Age Group Patient Characteristics Dose Form Used in combination to treat Hemorrhoids Combination Product in combination with: Zinc oxide (DB09321), Bismuth subgallate (DB13909) ••• ••• •••••••• - Contraindications & Blackbox Warnings
Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Categories
- Drug Categories
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- A6I4E79QF1
- CAS number
- 1304-76-3
- InChI Key
- WMWLMWRWZQELOS-UHFFFAOYSA-N
- InChI
- InChI=1S/2Bi.3O
- IUPAC Name
- [(oxobismuthanyl)oxy]bismuthanone
- SMILES
- O=[Bi]O[Bi]=O
References
- General References
- Not Available
- External Links
- ChemSpider
- 14093
- 19472
- Wikipedia
- Bismuth(III)_oxide
Clinical Trials
- Clinical Trials
Phase Status Purpose Conditions Count 4 Completed Treatment Helicobacter Pylori Infection 1 4 Unknown Status Treatment Helicobacter Pylori Infection 2 3 Completed Treatment Haemorrhoids 1
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
- Not Available
- Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source logP -0.13 Chemaxon pKa (Strongest Basic) -3 Chemaxon Physiological Charge 0 Chemaxon Hydrogen Acceptor Count 2 Chemaxon Hydrogen Donor Count 0 Chemaxon Polar Surface Area 43.37 Å2 Chemaxon Rotatable Bond Count 2 Chemaxon Refractivity 4.24 m3·mol-1 Chemaxon Polarizability 7.36 Å3 Chemaxon Number of Rings 0 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter No Chemaxon Veber's Rule No Chemaxon MDDR-like Rule No Chemaxon - Predicted ADMET Features
- Not Available
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
- Not Available
- Chromatographic Properties
Collision Cross Sections (CCS)
Not Available
Drug created at November 24, 2020 15:40 / Updated at November 25, 2020 17:34